US4217353A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for inducing anorexia
Assignee: Bristol Myers Squibb Pharma Co
•
Filing: 1979-04-06
•
Granted: 1980-08-12
•
Expires: 1999-04-06
Abstract
Abstract Naltrexone is administered orally so as to effect appetite suppression in mammals.
Inventors
- 👤 Dewey H. Smith, Jr.
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-06 01:44
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/435; A61K31/47; A61K31/485; A61P; A61P3/00; A61P3/04
Claims Analysis
Total Claims: 4
Claim 1
Independent Claim
29 words
A method for exerting an anorexigenic effect in a mammal which comprises orally administering to said mammal an effective anorexigenic amount of naltrexone or a pharmaceutically effective salt thereof.
Claim 2
Independent Claim
29 words
A method for exerting an anorexigenic effect in a mammal which comprises orally administering to said mammal an effective anorexigenic amount of naltrexone or a pharmaceutically effective salt thereof.
Claim 3
Dependent Claim
12 words
The method of claim 1 wherein said mammal is a human being.
Claim 4
Dependent Claim
16 words
The method of claim 2 wherein said effective dose ranges between 10 and 100 mg daily.
References Cited (Backward Citations)
US3332950A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1983-08-12 | 1984-02-11 | 1984-08-12 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1987-08-12 | 1988-02-11 | 1988-08-12 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1991-08-12 | 1992-02-11 | 1992-08-12 | $7700.00 | Window Closed / Lapsed |